Skip to main content
. 2020 Jan 30;10:1659. doi: 10.3389/fphar.2019.01659

Table 3.

Comparisons between the characteristics of users and non-users of psychotropic molecules.

Non-users of psychotropic molecules n = 115 Users of psychotropic molecules n = 62 p-value
Age 67.77 ± 9.13 72.49 ± 8.74 <.001b
Education (years) 12.00 ± 4.07 11.09 ± 3.89 NSb
Falls with injury, number (%) 61 (60.40%) 51 (67.11%) NSc
Risk factors of falls 0.80 ± 0.75 1.01 ± 1.11 NSb
Number of prescribed molecules 3.37 ± 3.02 7.39 ± 3.97 <.001b
Comorbidities 1.50 ± 1.28 2.09 ± 1.57 <.009b
Handgrip strength (kg) 23.13 ± 8.59 20.79 ± 8.13 .023b
BMI 27.20 ± 4.96 27.75 ± 5.09 NSa
MMSE score 28.29 ± 1.86 26.95 ± 2.96 .002b
MoCA score 27.48 ± 2.77 25 ± 5.14 <.001b
TMT A, completion time (sec) 36.24 ± 14.74 43.43 ± 22.87 .006 b
TMT B, completion time (sec) 84.91 ± 38.78 108.73 ± 57.04 .001b
TMT B-A (sec) 49.29 ± 31.82 69.58 ± 49.54 .001b
TUG score (sec) 8.70 ± 1.75 10.36 ± 4.18 .002b

Unless indicated, values are mean ± SD; aStudent’s t-test, bMann-Whitney U test, cChi square test, NS (non-significant), SD (standard deviation).